Medical Staff Portal
News, Alerts & Events

Erythromycin estolate 50 mg/mL oral suspension

October 10 , 2017

The Issue:

Erythromycin estolate 50 mg/mL oral suspension has been discontinued.  The only Canadian manufacturer of this product is Teva.

Once the remaining inventory is expired or depleted, erythromycin estolate oral solution will no longer be available.  In addition, there are no other erythromycin oral suspensions nor any other erythromycin estolate formulations on the Canadian market.

Key changes include:

Physicians should be aware of the discontinuation of erythromycin estolate suspension, and the lack of the availability of any other erythromycin oral liquid formulation.

Alternatives are either azithromycin 40mg/mL or clarithromycin 50mg/mL oral suspension at appropriate equivalent doses.

*Alternatives are provided for clinician information and may not be appropriate for all clinical situations.  The information provi9ded does not replace clinician judgement.


Please post this notice in your area and ensure all staff is informed about the change.


Please contact your site pharmacy department with any questions or concerns.



Download PDF